Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;32(10):1857-1869.
doi: 10.1002/oby.24085.

Poor muscle health and cardiometabolic risks associated with antidepressant treatment

Affiliations

Poor muscle health and cardiometabolic risks associated with antidepressant treatment

Patrik Andersson et al. Obesity (Silver Spring). 2024 Oct.

Abstract

Objective: This study aims to investigate whether antidepressant users display differences in fat distribution and muscle composition relative to non-users and to explore risk factors for developing cardiovascular disease (CVD) and type 2 diabetes.

Methods: The study used quantitative adipose and muscle tissue measures derived from magnetic resonance imaging data from UK Biobank (N = 40,174). Fat distribution and muscle composition of selective serotonin reuptake inhibitor (SSRI) and tricyclic antidepressant (TCA) users were compared with sex-, age-, and BMI-matched control individuals. Cox regression models were used to test for increased risk of developing CVD and type 2 diabetes.

Results: SSRI users had more visceral fat, smaller muscle volume, and higher muscle fat infiltration compared with matched control individuals. Female users showed a larger increase in BMI over time compared with male users. However, male users displayed an unhealthier body composition profile. Male SSRI users also had an increased risk of developing CVD. Both male and female TCA users showed lower muscle volume and an increased risk of developing type 2 diabetes.

Conclusions: Adverse changes in body composition of antidepressant users are not captured by tracking the body weight or the BMI of the patients. These changes may lead to a worsened cardiometabolic risk profile.

PubMed Disclaimer

References

REFERENCES

    1. McCool A, Lukas K, Hayes P, Kelly D. Antidepressant medication prescribing patterns in Irish general practice from 2016 to 2020 to assess for long‐term use. Ir J Med Sci. 2022;191:2239‐2246.
    1. Morkem R, Barber D, Williamson T, Patten SB. A Canadian primary care sentinel surveillance network study evaluating antidepressant prescribing in Canada from 2006 to 2012. Can J Psychiatry. 2015;60:564‐570.
    1. Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009;66:848‐856.
    1. Huijbregts KM, AdriaanW H, Slottje P, van Balkom AJLM, Batelaan NM. Long‐term and short‐term antidepressant use in general practice: data from a large cohort in The Netherlands. Psychother Psychosom. 2017;86:362‐369.
    1. Lunghi C, Dugas M, Leclerc J, et al. Global prevalence of antidepressant drug utilization in the community: protocol for a systematic review. BMJ Open. 2022;12:e062197.

MeSH terms

Substances

LinkOut - more resources